Biomea Fusion is trading at $0.67, up 5.41% after hours, with no clear company-specific announcement identified for October 26.

  • The latest company release located was October 13’s Phase 1 BMF-650 results; this is prior news, not a confirmed catalyst for the move.
  • The supplied market context shows the S&P 500 and Nasdaq higher, providing a broader positive backdrop but not establishing why the stock rose after hours.